MedTrace Logo

Pulmonary Function in Non-hospitalized Adults and Children After Mild COVID-19

NCT06318208 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2024-03-26

No results posted yet for this study

Summary

The study investigates whether patients with mild SARS-CoV-2 infection, who stayed at home during their infection and weren't hospitalized, have any persisting sequelae in pulmonary function.

Therefore, 110 patients, aged 6-60 years, were recruited by telephone 4-12 weeks after laboratory-confirmed positive PCR and invited for a lung function testing. Every patient with abnormalities in pulmonary function was invited to a follow-up 3 months after the first appointment to assess changes in lung function values.

Patients with a pre-existing lung disease and smokers within the last five years were excluded beforehand.

Additionally to lung function testing we did a throat swab at each appointment to analyse via Multiplex PCR whether the patients had any other respiratory infection at the time of the pulmonary function testing.

Conditions

Interventions

DIAGNOSTIC_TEST

lung function testing

lung function testing including LCI, FEV1, FVC, DLCO

Sponsors & Collaborators

  • University of Rostock

    lead OTHER

Principal Investigators

  • Manfred Ballmann, Prof. Dr. · UMR Kinder- und Jugendklinik

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2022-01-03
Completion
2022-01-03

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06318208 on ClinicalTrials.gov